FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

19492811000001108: Trajenta 5mg tablets (Boehringer Ingelheim Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66077301000001119 Trajenta 5mg tablets (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66077401000001110 Trajenta 5mg tablets (Boehringer Ingelheim Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Is a Linagliptin 5mg tablets true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Linagliptin false Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Is a Trajenta true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Has active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has AMP True Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start